Synapsoft logo
AI Insights from Disclosures
Searching...
PROTIA INC. 303360
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
PROTIA INC. engages in the development, manufacture, and sale of in-vitro diagnostic medical devices across various product categories based on core immunodiagnostic technology, with its main business being the manufacture and sale of various immunochemical in-vitro diagnostic kits, including its flagship products for human allergy diagnosis, animal allergy diagnosis, and autoimmune disease diagnosis. The in-vitro diagnostic medical devices the company produces correspond to the 'testing' process, the second of the four processes in the bio, health, and medical fields consisting of prevention, testing, treatment, and management.
Representative Director Lim Gukjin
Founded March 22, 2000
Corporation Type KOSDAQ
Industry Classification Manufacture of medical and dental instruments and supplies
Corporate number 11011-1915094
Business number 110-81-45244
Phone Number 02-6968-5277
Fax Number 02-6442-8345
Company Address 401 Yangcheon-ro, Gangseo-gu, Seoul
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant